IntuitiveX leverages artificial intelligence across digital health, biotech, pharma, and medical devices. It navigates medical IP innovation, transporting healthcare innovations from idea to commercialization.

IntuitiveX

IntuitiveX | 2,254 followers on LinkedIn. An AI-First Medical Innovation Incubator and Consultancy with a portfolio of 3/12 FDA Breakthrough Device Companies | IntuitiveX is an AI-first medical innovation incubator and consultancy that specializes in intellectual property and providing commercialization services to grow companies no matter what stage they are in across medical devices, biotech, pharma, and digital health.

As IP &amp; commercialization experts, we discover and unlock the potential of breakthrough ideas by applying our extensive network and resources to make them possible.

President & Chief Legal Officer

Mark Han

Corporate VP and Managing Director (Microsoft Research) | Board Director (ResMed + Washington Research Foundation) | Startup and Real Estate…

Desney Tan

Managing Partner at IX Innovation LLC

Simon Robinson

CEO at Amplify Surgical

Andy Choi

Congratulations to @Neuro20 Technologies for their recognition at @ShepherdCenter in Atlanta! #Neuro20 #InnovateHealth #SuitUp2gether

Embracing the power of technology to overcome challenges. Meet Tony, a true inspiration who's not letting anything hold him back. #SuitUp With bilateral prosthetics, Tony shows us that resilience knows no bounds. We're honored to be a part of his journey with #Neuro20 as he aims to "Make Hard Better." Thank you for sharing your story, Tony. Together, we're breaking barriers and moving forward! #SuitUp2gether #Tech2MoveU

IX Innovation, a medical IP creation and monetization company and portfolio company of IntuitiveX, in partnership with ipCapital Group , is thrilled to announce the grant of a landmark patent for a voice-controlled medical copilot designed to revolutionize surgical procedures. The U.S. Patent and Trademark Office (USPTO) issued U.S. Patent 11,896,324 entitled “System for transcribing and performing analysis on patient data". This innovative technology, the brainchild of a team led by Dr. Jeffrey Roh , CEO of IntuitiveX, Dr. Justin Esterberg, an orthopedic surgery specialist, and John Cronin , Chairman and CEO of ipCapital Group, marks a new era in medical procedures that leverages AI/ML to provide patient-specific analysis, diagnosis and surgical control. This pioneering technology incorporates voice command capabilities into robotic surgical systems, offering surgeons enhanced precision and efficiency. This innovation is set to redefine surgical methodologies and patient care, marking a critical milestone in IX Innovation's commitment to revolutionizing medical technology. Under the guidance of Dr. Roh, a renowned figure in medical innovation, and Dr. Esterberg, with his profound expertise in orthopedic surgery, alongside Mr. Cronin, a pioneer in intellectual property strategy, this patent exemplifies IX Innovation's dedication to evolving medical practices through innovative solutions. The medical copilot patent embodies a new era in surgical procedures, promising significant impact on the medical industry by broadening the capabilities of robotic surgery and elevating the standards of patient treatment. IX Innovation, together with ipCapital, continues to lead the charge in healthcare innovation, developing technologies that not only improve patient outcomes but also transform medical practices. For more information, please contact: Simon Robinson – srobinson@intuitivex.com A link to preview the issued U.S. Patent 11,896,324: https://lnkd.in/gDfYjQRH

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 12, 2024 8:24 AM	452533ea
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 12, 2024 8:24 AM	3daec83b
crunchbase trigger	general	Nov 12, 2024 8:24 AM	476579f5
crunchbase profile	general
li profile	general	Nov 12, 2024 8:24 AM	fe16a977
translate crunchbase fundingrounds	general
peers	general	Nov 12, 2024 8:24 AM	7f84f59a
news basic	general	Nov 12, 2024 8:24 AM	327495c5
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

INTU

COM:INTUITIVEX

IntuitiveX